Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1989;13:549-557

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Imai, Y.
Right arrow Articles by Yoshinaga, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Imai, Y.
Right arrow Articles by Yoshinaga, K.

Hypertension, Vol 13, 549-557, Copyright © 1989 by American Heart Association


ARTICLES

Role of vasopressin in cardiovascular response to central cholinergic stimulation in rats

Y Imai, K Abe, S Sasaki, N Minami, M Munakata, S Yumita, T Nobunaga, H Sekino and K Yoshinaga
Department of Medicine, Tohoku University School of Medicine, Sendai, Japan.

The cardiovascular effects of centrally administered cholinomimetics were examined in conscious Long-Evans and Brattleboro rats. Carbachol (1 microgram/kg) or physostigmine (50 micrograms/kg) induced a long- lasting increase in blood pressure and a decrease in heart rate in Long- Evans rats whereas no bradycardia was observed in Brattleboro rats, and the pressor response was significantly less than that in Long-Evans rats. The cardiovascular responses to nicotine (30 micrograms/kg) in Brattleboro rats were not different from those in Long-Evans rats. Intravenous vasopressin antagonist, d(CH2)5Tyr(Me) arginine vasopressin, significantly attenuated the pressor response and eliminated the bradycardic response to carbachol in Long-Evans rats. However, the pressor response to carbachol in Brattleboro rats was still significantly less than that in Long-Evans rats treated with vasopressin antagonist. Intravenous phentolamine partially inhibited the pressor response to carbachol in Long-Evans rats and completely eliminated it in Brattleboro rats. Combined intravenous treatment with phentolamine and vasopressin antagonist completely eliminated the pressor response to carbachol in Long-Evans rats. Centrally administered methylatropine eliminated either the hypertensive or bradycardic response to carbachol in Long-Evans rats. These results indicate that the pressor and bradycardic response to carbachol or physostigmine is mediated by the central muscarinic receptor mechanism. Hypertensive response to intracerebroventricularly administered carbachol in normal rats is mediated both by an increase in central sympathetic outflow and in circulating vasopressin. The bradycardia seems to be mediated mainly by vasopressin.


This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
L. Shi, C. Mao, F. Zeng, L. Zhu, and Z. Xu
Central cholinergic mechanisms mediate swallowing, renal excretion, and c-fos expression in the ovine fetus near term
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2009; 296(2): R318 - R325.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. V. Menani, S. P. Barbosa, L. A. De Luca Jr., J. I. F. De Gobbi, and A. K. Johnson
Serotonergic mechanisms of the lateral parabrachial nucleus and cholinergic-induced sodium appetite
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2002; 282(3): R837 - R841.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. H. Eckel
Obesity and Heart Disease : A Statement for Healthcare Professionals From the Nutrition Committee, American Heart Association
Circulation, November 4, 1997; 96(9): 3248 - 3250.
[Full Text]